U.S., Nov. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07229118) titled 'A Study to Evaluate COR-1004 in Adult Volunteers.' on Nov. 13.
Brief Summary: This research study is being done to see if a new, injectable drug called COR-1004 is safe for people to take. It will also help doctors find the right dose of the drug. The study will look at how different dose levels of COR-1004 affect the levels of LDL cholesterol (often called "bad" cholesterol) in the blood. The study will enroll otherwise healthy volunteers who have LDL cholesterol of 100 mg/dl or higher but are not currently taking any cholesterol-lowering medicines.
The main purpose of this study is to test a new drug, COR-1004. Researchers want t...